Nirupoma Medicure India Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
as on 25-12-2024
- Paid Up Capital ₹ 1.30 Cr
as on 25-12-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.97 M
as on 25-12-2024
- Satisfied Charges ₹ 7.50 Cr
as on 25-12-2024
- Revenue 26.84%
(FY 2022)
- Profit 24.00%
(FY 2022)
- Ebitda 105.64%
(FY 2022)
- Net Worth 25.12%
(FY 2022)
- Total Assets 18.12%
(FY 2022)
About Nirupoma Medicure India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 1.30 Cr.
The company currently has active open charges totaling ₹5.97 M. The company has closed loans amounting to ₹7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tridip Chetia and Swapnali Chetia serve as directors at the Company.
- CIN/LLPIN
U85110AS2001PTC006623
- Company No.
006623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2001
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Dibrugarh, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nirupoma Medicure India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapnali Chetia  | Managing Director | 13-Sep-2001 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tridip Chetia | Director | 13-Sep-2001 | Current |
Financial Performance of Nirupoma Medicure India.
Nirupoma Medicure India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.84% increase. The company also saw a substantial improvement in profitability, with a 24% increase in profit. The company's net worth Soared by an impressive increase of 25.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirupoma Medicure India?
In 2019, Nirupoma Medicure India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 26 Jul 2022 | ₹2.00 M | Open |
Central Bank Of India Creation Date: 08 Jan 2013 | ₹0.97 M | Open |
Central Bank Of India Creation Date: 24 Sep 2009 | ₹1.50 M | Open |
How Many Employees Work at Nirupoma Medicure India?
Nirupoma Medicure India has a workforce of 31 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirupoma Medicure India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirupoma Medicure India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
